Giant Gene Banks Take on Disease
By Erika Check Hayden,
Nature
| 10. 14. 2014
Early last year, three researchers set out to create one genetic data set to rule them all. The trio wanted to assemble the world’s most comprehensive catalogue of human genetic variation, a single reference database that would be useful to researchers hunting rare disease-causing genetic variants.
Unlike past ‘big data’ projects, which have involved large groups of scientists, this one deliberately kept itself small, deploying just five analysts. Nearly two years in, it has identified about 50 million genetic variants — points at which one person’s DNA differs from another’s — in whole-genome sequence data collected by 23 other research collaborations. The group, called the Haplotype Reference Consortium, will unveil its database in San Diego, California, on 20 October, at the annual meeting of the American Society of Human Genetics.
Geneticists have not always been so willing to share data. But that seems to be changing. “It’s been surprisingly easy to bring all these data sets together,” says Jonathan Marchini, a statistical geneticist at the University of Oxford, UK, and one of the consortium’s leaders. “There is a lot of...
Related Articles
By Darren Incorvaia, Fierce Biotech | 07.16.2026
Jennifer Doudna, Ph.D., the Nobel Laureate best known for co-inventing the CRISPR system that has become the foundation for gene editing, is dipping her toes into a new, buzzy field: AI-powered protein design.
In a new paper, published today...
By Risa Cromer, The Conversation | 07.17.2026
By Emily Packard Dawson and Lainie Friedman Ross , The Hastings Center for Bioethics | 07.16.2026
Major news outlets recently reported – based on a bioRxiv preprint – that scientists had edited genes in human embryos with “startling precision.” The scientists’ decision to release this work ahead of peer review, coupled with the extensive media coverage...
Media coverage of recent developments in embryo gene editing might seem to suggest that gene-edited babies are close to becoming a reality. As tech billionaires eager to profit off of techno-eugenics invest in “designer baby” technologies, attempts to normalize heritable genome editing – which remains unsafe and raises significant ethical and societal concerns – are especially dangerous. It’s worth taking a closer look at these developments and what they mean, in a way that pushes back on narratives normalizing the...